Kallieri, M.; Hillas, G.; Loukides, S.; Kostikas, K.; Gogali, A.
Cardiometabolic Comorbidities in COPD: Focus on Diabetes, GLP-1 Receptor Agonists, SGLT-2 Inhibitors and Antidiabetic Drugs. J. Clin. Med. 2026, 15, 2082.
https://doi.org/10.3390/jcm15052082
AMA Style
Kallieri M, Hillas G, Loukides S, Kostikas K, Gogali A.
Cardiometabolic Comorbidities in COPD: Focus on Diabetes, GLP-1 Receptor Agonists, SGLT-2 Inhibitors and Antidiabetic Drugs. Journal of Clinical Medicine. 2026; 15(5):2082.
https://doi.org/10.3390/jcm15052082
Chicago/Turabian Style
Kallieri, Maria, Georgios Hillas, Stelios Loukides, Konstantinos Kostikas, and Athena Gogali.
2026. "Cardiometabolic Comorbidities in COPD: Focus on Diabetes, GLP-1 Receptor Agonists, SGLT-2 Inhibitors and Antidiabetic Drugs" Journal of Clinical Medicine 15, no. 5: 2082.
https://doi.org/10.3390/jcm15052082
APA Style
Kallieri, M., Hillas, G., Loukides, S., Kostikas, K., & Gogali, A.
(2026). Cardiometabolic Comorbidities in COPD: Focus on Diabetes, GLP-1 Receptor Agonists, SGLT-2 Inhibitors and Antidiabetic Drugs. Journal of Clinical Medicine, 15(5), 2082.
https://doi.org/10.3390/jcm15052082